Literature DB >> 4342436

Purification and characterization of lymphocyte mediators in cellular immunity: comparative studies on migration inhibitory factor (MIF) chemotactic factor for macrophages and lymphotoxin.

H G Remold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4342436     DOI： 10.1111/j.1600-065x.1972.tb01542.x

Source DB:  PubMed          Journal:  Transplant Rev        ISSN： 0082-5948


× No keyword cloud information.
  9 in total

1.  Mediation of macrophage effector function by lymphokine.

Authors:  L W Poulter; J L Turk
Journal:  Agents Actions       Date:  1976-02

Review 2.  Human lymphoid cell lines: models for immunological analysis.

Authors:  P R Glade; P S Papageorgiou
Journal:  In Vitro       Date:  1973 Nov-Dec

3.  Partial characterization of an immunoenhancing factor from allogeneic human lymphocyte cell lines.

Authors:  A S Rubin; A B Macdonald
Journal:  Immunology       Date:  1976-01       Impact factor: 7.397

4.  Hypersensitivity reactions in the small intestine. 2. Effects of allograft rejection on mucosal architecture and lymphoid cell infiltrate.

Authors:  T T MacDonald; A Ferguson
Journal:  Gut       Date:  1976-02       Impact factor: 23.059

5.  Hapten-specific responses to contact sensitizers. Use of fluorodinitrobenzene to elicit migration inhibition and macrophage agglutination factors from lymph node cells of contact-sensitive guinea-pigs.

Authors:  H P Godfrey
Journal:  Immunology       Date:  1976-05       Impact factor: 7.397

6.  Isolation and partial characterization of an antibody enhancing factor from leukaemic owl monkey cell cultures.

Authors:  A B MacDonald; C E Fraser; A S Rubin
Journal:  Immunology       Date:  1978-01       Impact factor: 7.397

7.  Purification of thymic macrophage migration inhibitory factor (MIF).

Authors:  J C Houck; C M Chang
Journal:  Inflammation       Date:  1976-03       Impact factor: 4.092

8.  Requirement for alpha-L-fucose on the macrophage membrane receptor for MIF.

Authors:  H G Remold
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

9.  Specific heterologous enhancement of immune responses. VI. Partial purification of a nonspecific enhancing factor from supernates of allogeneically stimulated human lymphocyte cell lines.

Authors:  A S Rubin; A B MacDonald; A H Coons
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.